![David L. Brinkley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de David L. Brinkley
Antiguos cargos conocidos de David L. Brinkley.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARATANA THERAPEUTICS INC | Director/Miembro de la Junta | 27/03/2014 | 18/07/2019 |
Independent Dir/Board Member | 27/03/2014 | 18/07/2019 | |
INNOVIVA, INC. | Corporate Officer/Principal | 16/07/2009 | 01/07/2013 |
Smithkline Beckman Corp
![]() Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Corporate Officer/Principal | 01/01/1995 | 01/01/1995 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/1995 | - |
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Director/Miembro de la Junta | 01/01/2013 | - |
Formación de David L. Brinkley.
The Johns Hopkins University | Graduate Degree |
Kent State University (Ohio) | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Graduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INNOVIVA, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Smithkline Beckman Corp
![]() Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Health Technology |
Aratana Therapeutics, Inc.
![]() Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Bolsa de valores
- Insiders
- David L. Brinkley
- Experiencia